Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily tadalafil to improve intermittent claudication in men with erectile dysfunction and peripheral vascular disease
2006-005399-42Phase 4Terminated
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of tadalafil in peripheral artery occlusion (PAD), intermittent claudication (IC) and erectile dysfunction (ED), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoints: Exercise treadmill duration and Time to first leg pain. Started Aug 2011; status: terminated.
02
Drugs
tadalafil
03
Conditions
peripheral artery occlusion (PAD)intermittent claudication (IC)erectile dysfunction (ED)
Beyond the preview
Go deeper on 2006-005399-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005399-42.